Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody

Ranjibar, Farideh and Habibi-Anbouhi, Mahdi and Kazemi-Lomedasht, Fatemeh and Aghaee-Bakhtiyari, Seyed Hamid and Alirahimi, Ehsan and Behdani, Mahdi (2018) Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody. Iranian Journal of Basic Medical Sciences, 21 (9). pp. 884-888.

[img] Text
IJBMS_Volume 21_Issue 9_Pages 884-888.pdf

Download (548kB)
Official URL: http://ijbms.mums.ac.ir/article_11206.html


Objective(s): Filamentous bacteriophage M13 was genetically engineered to specifically target mammalian cells for gene delivery purpose. Materials and Methods: A vascular endothelial growth factor receptor 2 (VEGFR2)-specific nanobody was genetically fused to the capsid gene III of M13 bacteriophage (pHEN4/3VGR19). A mammalian expression construct containing Cop-green fluorescent protein (Cop-GFP), as a reporter gene, was amplified by PCR and then sub-cloned in the pHEN4/3VGR19 phagemid. The resulting construct was transfected into 293KDR cell. The recombinant phage was extracted and confirmed and then transduced into VEGFR2 expressing cell (293KDR). Results: Seventy-two hr after transfection, green fluorescence was detected in 30 of the cells. About 1 of the cells which transduced by recombinant phages were able to express GFP. Conclusion: It is hoped that the results from this study will help to find potential vectors to improve the efficiency of gene delivery. Taken together, we conclude that this newly-introduced vector can be used in cancer researches.

Item Type: Article
Subjects: QV pharmacology
Divisions: Journals > Iranian J Basic Medical Sciences
Depositing User: ijbms ijbms
Date Deposited: 02 Oct 2018 08:58
Last Modified: 02 Oct 2018 08:58
URI: http://eprints.mums.ac.ir/id/eprint/10352

Actions (login required)

View Item View Item